Screening for rheumatic heart disease: Current approaches and controversies

Nature Reviews Cardiology

Volumn 10, Issue 1, 2013, Pages 49-58

  Roberts, Kathryn ^a   Colquhoun, Samantha ^a   Steer, Andrew ^b   Reményi, Bo ^a   Carapetis, Jonathan ^c  

^a MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BENZATHINE PENICILLIN; PENICILLIN DERIVATIVE;

ANTIBIOTIC PROPHYLAXIS; AUSCULTATION; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC EQUIPMENT; DISEASE SEVERITY; ECHOCARDIOGRAPHY; ENDOCARDITIS; FOLLOW UP; GROUP A STREPTOCOCCAL INFECTION; HUMAN; MASS SCREENING; MORBIDITY; MORTALITY; PATIENT COMPLIANCE; PRIORITY JOURNAL; REVIEW; RHEUMATIC HEART DISEASE; SECONDARY PREVENTION; SENSITIVITY ANALYSIS;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DIAGNOSTIC IMAGING; ECHOCARDIOGRAPHY, DOPPLER, COLOR; FEMALE; HEART AUSCULTATION; HEART FUNCTION TESTS; HUMANS; MALE; MASS SCREENING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RHEUMATIC HEART DISEASE;

EID: 84871736005     PISSN: 17595002     EISSN: 17595010     Source Type: Journal    
DOI: 10.1038/nrcardio.2012.157     Document Type: Review

References (86)

1. Carapetis, J. R., Steer, A. C., Mulholland, E. K. & Weber, M. The global burden of group A streptococcal diseases. Lancet Infect. Dis. 5, 685-694 (2005). (Pubitemid 41505357)
2. WHO. Prevention of rheumatic fever: Report of a WHO expert committee. WHO Technical Report Series, No. 342 (1966).
3. Marijon, E. et al. Prevalence of rheumatic heart disease detected by echocardiographic screening. N. Engl. J. Med. 357, 470-476 (2007). (Pubitemid 47204876)
4. Carapetis, J. R. et al. Evaluation of a screening protocol using auscultation and portable echocardiography to detect asymptomatic rheumatic heart disease in Tongan schoolchildren. Nat. Clin. Pract. Cardiovasc. Med. 5, 411-417 (2008). (Pubitemid 351935575)
5. Bhaya, M., Panwar, S., Beniwal, R. & Panwar, R. B. High prevalence of rheumatic heart disease detected by echocardiography in school children. Echocardiography 27, 448-453 (2010).
6. Paar, J. A. et al. Prevalence of rheumatic heart disease in children and young adults in Nicaragua. Am. J. Cardiol. 105, 1809-1814 (2010).
7. Webb, R. H. et al. Optimising echocardiographic screening for rheumatic heart disease in New Zealand: not all valve disease is rheumatic. Cardiol. Young 21, 436-443 (2011).
8. Saxena, A. et al. Prevalence and outcome of subclinical rheumatic heart disease in India: the RHEUMATIC (Rheumatic Heart Echo Utilisation and Monitoring Actuarial Trends in Indian Children) study. Heart 97, 2018-2022 (2011).
9. Beaton, A. et al. Echocardiography screening for rheumatic heart disease in Ugandan schoolchildren. Circulation 125, 3127-3132 (2012).
10. Kothari, S. S. Letter by Kothari regarding article, "Rheumatic heart disease screening by echocardiography: The inadequacy of World Health Organization criteria for optimizing the diagnosis of subclinical disease". Circulation 121, e420; author reply e423 (2010).
11. DeGroff, C. G. Letter by DeGroff regarding article, "Rheumatic heart disease screening by echocardiography: The inadequacy of World Health Organization criteria for optimizing the diagnosis of subclinical disease". Circulation 121, e421; author reply e423 (2010).
12. Steer, A. C. & Carapetis, J. R. Prevention and treatment of rheumatic heart disease in the developing world. Nat. Rev. Cardiol. 6, 689-698 (2009).
13. Marijon, E. et al. Echocardiographic screening for rheumatic heart disease. Bull. World Health Organ. 86, 84 (2008). (Pubitemid 351213707)
14. Remenyi, B. et al. World Heart Federation criteria for echocardiographic diagnosis of rheumatic heart disease-an evidence-based guideline. Nat. Rev. Cardiol. 9, 297-309 (2012).
15. Wilson, J. & Jungner, G. Principles and practice of screening for disease. WHO Public Health Papers, No. 34 (1968).
16. Council of Europe. Committee of Ministers. Recommendation No. R (94) 11 on Screening as a Tool of Preventive Medicine (1994).
17. WHO. Global Burden of Disease (GBD) 2010 study [online], http://www.who.int/healthinfo/global-burden-disease/GBD-2005-study/en/index. html (2012).
18. Parnaby, M. G. & Carapetis, J. R. Rheumatic fever in indigenous Australian children. J. Paediatr. Child Health 46, 527-533 (2010).
19. Longo-Mbenza, B. et al. Survey of rheumatic heart disease in school children of Kinshasa town. Int. J. Cardiol. 63, 287-294 (1998). (Pubitemid 28150008)
20. Rizvi, S. F. et al. Status of rheumatic heart disease in rural Pakistan. Heart 90, 394-399 (2004). (Pubitemid 38406912)
21. Sadiq, M. et al. Prevalence of rheumatic heart disease in school children of urban Lahore. Heart 95, 353-357 (2009).
22. Ba-Saddik, I. A. et al. Prevalence of rheumatic heart disease among school-children in Aden, Yemen. Ann. Trop. Paediatr. 31, 37-46 (2011).
23. Carapetis, J. R. Rheumatic heart disease in Asia. Circulation 118, 2748-2753 (2008).
24. Jackson, S. J., Steer, A. C. & Campbell, H. Systematic Review: estimation of global burden of non-suppurative sequelae of upper respiratory tract infection: rheumatic fever and post-streptococcal glomerulonephritis. Trop. Med. Int. Health 16, 2-11 (2011).
25. Bland, E. & Jones, T. Rheumatic fever and rheumatic heart disease. A twenty-year report on 1, 000 patients followed since childhood. Circulation 4, 836-843 (1951).
26. Cohn, A. E. & Lingg, C. The natural history of rheumatic cardiac disease: a statistical study: I. Onset and duration of disease. JAMA 121, 1-8 (1943).
27. Jaiyesimi, F. & Antia, A. U. Childhood rheumatic heart disease in Nigeria. Trop. Geogr. Med. 33, 8-13 (1981). (Pubitemid 11091202)
28. Günther, G., Asmera, J. & Parry, E. Death from rheumatic heart disease in rural Ethiopia. Lancet 367, 391 (2006). (Pubitemid 43184248)
29. Kumar, R., Raizada, A., Aggarwal, A. K. & Ganguly, N. K. A community-based rheumatic fever/rheumatic heart disease cohort: twelve-year experience. Indian Heart J. 54, 54-58 (2002).
30. Lloyd-Jones, D. et al. Heart disease and stroke statistics\2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 119, 480-486 (2009).
31. Quinn, R. W. Comprehensive review of morbidity and mortality trends for rheumatic fever, streptococcal disease, and scarlet fever: the decline of rheumatic fever. Rev. Infect. Dis. 11, 928-953 (1989).
32. Massell, B. F., Chute, C. G., Walker, A. M. & Kurland, G. S. Penicillin and the marked decrease in morbidity and mortality from rheumatic fever in the United States. N. Engl. J. Med. 318, 280-286 (1988). (Pubitemid 18034519)
33. Field, B. for the Australian Institute of Health and Welfare. Rheumatic Heart Disease: all but forgotten in Australia except amongst Aboriginal and Torres Strait Islander peoples. AIHW Bullentin No. 16, Cat. No. AUS 58 (2004).
34. Colquhoun, S. et al. An analysis of mortality trends for rheumatic heart disease and rheumatic fever in indigenous and non-indigenous Australians [poster]. XVIII Lancefield International Symposium (2011).
35. Carapetis, J. R. & Currie, B. J. Mortality due to acute rheumatic fever and rheumatic heart disease in the Northern Territory: a preventable cause of death in aboriginal people. Aust. N. Z. J. Public Health 23, 159-163 (1999). (Pubitemid 29332814)
36. Milne, R. J., Lennon, D., Stewart, J. M., Vander Hoorn, S. & Scuffham, P. A. Mortality and hospitalisation costs of rheumatic fever and rheumatic heart disease in New Zealand. J. Paediatr. Child Health 48, 692-697 (2012).
37. WHO. The global burden of disease: 2004 update [online], http://www.who.int/healthinfo/global-burden-disease/2004-report-update/en/index. html (2004).
38. Marijon, E., Mirabel, M., Celermajer, D. S. & Jouven, X. Rheumatic heart disease. Lancet 379, 953-964 (2012).
39. Carapetis, J. R. et al. Outcomes of cardiac valve replacement for rheumatic heart disease in aboriginal Australians. The Asia Pacific Heart Journal 8, 138-147 (1999). (Pubitemid 30077237)
40. North, R. A. et al. Long-term survival and valve-related complications in young women with cardiac valve replacements. Circulation 99, 2669-2676 (1999). (Pubitemid 29237455)
41. [No authors listed] The natural history of rheumatic fever and rheumatic heart disease. Ten-year report of a cooperative clinical trial of ACTH, cortisone, and aspirin. Circulation 32, 457-476 (1965).
42. Tompkins, D. G., Boxerbaum, B. & Liebman, J. Long-term prognosis of rheumatic fever patients receiving regular intramuscular benzathine penicillin. Circulation 45, 543-551 (1972).
43. Majeed, H. A. et al. The natural history of acute rheumatic fever in Kuwait: a prospective six year follow-up report. J. Chronic Dis. 39, 361-369 (1986). (Pubitemid 16099615)
44. Sanyal, S. K., Berry, A. M., Duggal, S., Hooja, V. & Ghosh, S. Sequelae of the initial attack of acute rheumatic fever in children from north India. A prospective 5-year follow-up study. Circulation 65, 375-379 (1982). (Pubitemid 12219034)
45. Feinstein, A. R. et al. Rheumatic fever in children and adolescents. A long-term epidemiologic study of subsequent prophylaxis, streptococcal infections, and clinical sequelae. Vii. Cardiac changes and sequelae. Ann. Intern. Med. 60 (Suppl. 5), 87-123 (1964).
46. Majeed, H. A., Batnager, S., Yousof, A. M., Khuffash, F. & Yusuf, A. R. Acute rheumatic fever and the evolution of rheumatic heart disease: a prospective 12 year follow-up report. J. Clin. Epidemiol. 45, 871-875 (1992).
47. Carapetis, J. R., Currie, B. J. & Mathews, J. D. Cumulative incidence of rheumatic fever in an endemic region: a guide to the susceptibility of the population? Epidemiol. Infect. 124, 239-244 (2000). (Pubitemid 30224132)
48. Sliwa, K. et al. Incidence and characteristics of newly diagnosed rheumatic heart disease in urban African adults: insights from the heart of Soweto study. Eur. Heart J. 31, 719-727 (2010).
49. Jones, T. D. Diagnosis of rheumatic fever. JAMA 126, 481-484 (1944).
50. Dajani, A. S. et al. Guidelines for the diagnosis of rheumatic fever. Jones Criteria, 1992 update. Special Writing Group of the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young of the American Heart Association. JAMA 268, 2069-2073 (1992).
51. Carapetis, J. R. et al. An Australian guideline for rheumatic fever and rheumatic heart disease: an abridged outline. Med. J. Aust. 186, 581-586 (2007). (Pubitemid 46929640)
52. Stollerman, G. H., Rusoff, J. H. & Hirschfeld, I. Prophylaxis against group A streptococci in rheumatic fever; the use of single monthly injections of benzathine penicillin G. N. Engl. J. Med. 252, 787-792 (1955).
53. Padmavati, S., Sharma, K. B. & Jayaram, O. Epidemiology and prophylaxis of rheumatic fever in Delhi\a five year follow-up. Singapore Med. J. 14, 457-461 (1973).
54. Feinstein, A. R. et al. A controlled study of three methods of prophylaxis against streptococcal infection in a population of rheumatic children. II. Results of the first three years of the study, including methods for evaluating the maintenance of oral prophylaxis. N. Engl. J. Med. 260, 697-702 (1959).
55. Wood, H. F., Feinstein, A. R., Taranta, A., Epstein, J. A. & Simpson, R. Rheumatic fever in children and adolescents: a long-term epidemiologic study of subsequent prophylaxis, streptococcal infections, and clinical sequelae: III. Comparative effectiveness of three prophylaxis regiments in preventing streptococcal infection and rheumatic recurrences. Ann. Intern. Med. 60, 31-46 (1964).
56. Feinstein, A. R., Stern, E. K. & Spagnuolo, M. The prognosis of acute rheumatic fever. Am. Heart J. 68, 817-834 (1964).
57. Lue, H. C. et al. Clinical and epidemiological features of rheumatic fever and rheumatic heart disease in Taiwan and the Far East. Indian Heart J. 35, 139-146 (1983).
58. Manyemba, J. & Mayosi, B. M. Penicillin for secondary prevention of rheumatic fever. Cochrane Database of Systematic Reviews 2002, Issue 3. Art No.: CD002227. http://dx.doi.org/10.1002/14651858.CD002227.
59. WHO. WHO Expert Consultation on Rheumatic Fever and Rheumatic Heart Disease (Geneva, 29 October-1 November 2001). WHO Technical Report Series 923 (2004).
60. Markowitz, M. & Lue, H. C. Allergic reactions in rheumatic fever patients on long-term benzathine penicillin G: the role of skin testing for penicillin allergy. Pediatrics 97, 981-983 (1996). (Pubitemid 26172653)
61. Lue, H. C., Chen, C. L. & Wei, H. Some problems in long-term prevention of streptococcal infection among children with rheumatic heart disease in Taiwan. Jpn Heart J. 17, 550-559 (1976). (Pubitemid 8005792)
62. Shah, B. et al. (2012). Rheumatic heart disease: progress and challenges in India. Indian J. Pediatr. http://dx.doi.org/10.1007/s12098-012-0853-2.
63. International Rheumatic Fever Study Group. Allergic reactions to long-term benzathine penicillin prophylaxis for rheumatic fever. Lancet 337, 1308-1310 (1991).
64. Carapetis, J. R. & Zühlke, L. J. Global research priorities in rheumatic fever and rheumatic heart disease. Ann. Pediatr. Cardiol. 4, 4-12 (2011).
65. Pelajo, C. F., Lopez-Benitez, J. M., Torres, J. M. & de Oliveira, S. K. Adherence to secondary prophylaxis and disease recurrence in 536 Brazilian children with rheumatic fever. Pediatr. Rheumatol. Online J. 8, 22 (2010).
66. Stewart, T., McDonald, R. & Currie, B. Acute rheumatic fever: adherence to secondary prophylaxis and follow up of Indigenous patients in the Katherine region of the Northern Territory. Aust. J. Rural Health 15, 234-240 (2007). (Pubitemid 47054712)
67. Nordet, P. WHO programme for the prevention of rheumatic fever/rheumatic heart disease in 16 developing countries: report from Phase I (1986-90). WHO Cardiovascular Diseases Unit and principal investigators. Bull. World Health Organ. 70, 213-218 (1992).
68. Steer, A. C. et al. High prevalence of rheumatic heart disease by clinical and echocardiographic screening among children in Fiji. J. Heart Valve Dis. 18, 327-335 (2009).
69. Reeves, B. M., Kado, J. & Brook, M. High prevalence of rheumatic heart disease in Fiji detected by echocardiography screening. J. Paediatr. Child Health 47, 473-478 (2011).
70. Mirabel, M. et al. Screening for rheumatic heart disease: evaluation of a simplified echocardiography-based approach. Eur. Heart J. Cardiovasc. Imaging http://dx.doi.org/10.1093/ehjci/jes077.
71. Marijon, E. et al. Rheumatic heart disease screening by echocardiography: the inadequacy of World Health Organization criteria for optimizing the diagnosis of subclinical disease. Circulation 120, 663-668 (2009).
72. Woolf, S. H. & Harris, R. The harms of screening: new attention to an old concern. JAMA 307, 565-566 (2012).
73. Peckham, C. S. & Dezateux, C. Issues underlying the evaluation of screening programmes. Br. Med. Bull. 54, 767-778 (1998). (Pubitemid 29000827)
74. Carapetis, J., Parr, J. & Cherian, T. Standardization of epidemiologic protocols for surveillance of post-streptococcal sequaelae: acute rhematic fever, rheumatic heart disease and acute post-streptococal glomerulonephritis. National Institute of Allergy and Infectious Diseases [online], http://www.niaid.nih.gov/topics/strepThroat/Documents/groupasequelae. pdf (2006).
75. Bhaya, M., Beniwal, R., Panwar, S. & Panwar, R. B. Two years of follow-up validates the echocardiographic criteria for the diagnosis and screening of rheumatic heart disease in asymptomatic populations. Echocardiography 28, 929-933 (2011).
76. Anabwani, G. M. & Bonhoeffer, P. Prevalence of heart disease in school children in rural Kenya using colour-flow echocardiography. East Afr. Med. J. 73, 215-217 (1996). (Pubitemid 126354456)
77. Freedman, B. Equipoise and the ethics of clinical research. N. Engl. J. Med. 317, 141-145 (1987). (Pubitemid 17092151)
78. Michaud, C. & Narula, J. in Rheumatic Fever (eds Narula, J., Virmani, R., Reddy, K. S. & Tandon, R.) 485-497 (American Registry of Pathology, Washington, DC, 1999).
79. Strasser, T. Cost-effective control of rheumatic fever in the community. Health Policy 5, 159-164 (1985). (Pubitemid 16242070)
80. Michaud, C., Gutierrez, J., Cruz, C. & Pearson, T. The World Bank Health Sector Priorities Review. Rheumatic Heart Disease 1-31 (World Bank, Washington, DC, 1991).
81. North, D. A., Heynes, R. A., Lennon, D. R. & Neutze, J. Analysis of costs of acute rheumatic fever and rheumatic heart disease in Auckland. N. Z. Med. J. 106, 400-403 (1993).
82. Sliwa, K. & Zilla, P. Rheumatic heart disease: the tip of the iceberg. Circulation 125, 3060-3062 (2012).
83. Colquhoun, S. M., Carapetis, J. R., Kado, J. H. & Steer, A. C. Rheumatic heart disease and its control in the Pacific. Expert Rev. Cardiovasc. Ther. 7, 1517-1524 (2009).
84. Viali, S., Saena, P. & Futi, V. Rheumatic Fever Programme in Samoa. N. Z. Med. J. 124, 26-35 (2011).
85. Viali, S. Rheumatic fever and rheumatic heart disease in Samoa. Pac. Health Dialog. 13, 31-38 (2006).
86. Colquhoun, S. M. et al. Pilot study of nurse-led rheumatic heart disease echocardiography screening in Fiji\a novel approach in a resource-poor setting. Cardiol. Young 8, 1-7 (2012).